M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
Open Access
- 28 July 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 30347
Abstract
Effects of M2 tumour-associated macrophages on the pathogenesis of diffuse large B cell lymphoma (DLBCL) are still controversial. Our data showed that the number of CD163-positive M2 macrophages correlated negatively with DLBCL prognosis. Macrophage depletion by clodronate liposomes significantly suppressed tumour growth in a xenograft mouse model of DLBCL using OCI-Ly3 cells. Moreover, M2 polarization of macrophages induced legumain expression in U937 cells. Exogenous legumain promoted degradation of fibronectin and collagen I, which was abolished by administration of a legumain inhibitor RR-11a. Overexpression of legumain in Raw 264.7 cells also induced tube formation of endothelial cells in matrigel. In the xenograft mouse model of DLBCL, decreased fibronectin and collagen I, as well as increased legumain expression and angiogenesis were found at the late stage tumours compared with early stage tumours. Co-localization of legumain and fibronectin was observed in the extracellular matrix of tumour tissues. Administration of the legumain inhibitor to the xenograft DLBCL model suppressed tumour growth, angiogenesis and collagen deposition compared with the control. Taken together, our results suggest that M2 tumour-associated macrophages affect degradation of the extracellular matrix and angiogenesis via overexpression of legumain and therefore play an active role in the progression of DLBCL.Keywords
This publication has 33 references indexed in Scilit:
- Toll-like receptor 4–induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphomaAnnals of Diagnostic Pathology, 2015
- High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal typeAnnals of Hematology, 2015
- Role of tumor‐associated macrophages in hematological malignanciesPathology International, 2015
- Exosome‐mediated extracellular release of polyadenylate‐binding protein 1 in human metastatic duodenal cancer cellsProteomics, 2014
- Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinomaLung Cancer, 2014
- Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironmentNature Communications, 2014
- Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulationProceedings of the National Academy of Sciences, 2013
- Selective ablation of tumor‐associated macrophages suppresses metastasis and angiogenesisCancer Science, 2013
- Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin LymphomaClinical Cancer Research, 2013
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T‐cell lymphoma (AITL)Pathology International, 2010